1.Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer
So Young KIM ; Kyung Un CHOI ; Chungsu HWANG ; Hyung Jung LEE ; Jung Hee LEE ; Dong Hoon SHIN ; Jee Yeon KIM ; Mee Young SOL ; Jae Ho KIM ; Ki Hyung KIM ; Dong Soo SUH ; Byung Su KWON
Journal of Pathology and Translational Medicine 2019;53(4):244-252
BACKGROUND: Ovarian epithelial cancer (OEC) is the second-most common gynecologic malignancy. CD109 expression is elevated in human tumor cell lines and carcinomas. A previous study showed that CD109 expression is elevated in human tumor cell lines and CD109 plays a role in cancer progression. Therefore, this study aimed to determine whether CD109 is expressed in OEC and can be useful in predicting the prognosis. METHODS: Immunohistochemical staining for CD109 and reverse transcription-quantitative polymerase chain reaction was performed. Then we compared CD109 expression and chemoresistance, overall survival, and recurrence-free survival of OEC patients. Chemoresistance was evaluated by dividing into good-response group and poor-response group by the time to recurrence after chemotherapy. RESULTS: CD109 expression was associated with overall survival (p = .020), but not recurrence-free survival (p = .290). CD109 expression was not an independent risk factor for overall survival due to its reliability (hazard ratio, 1.58; p = .160; 95% confidence interval, 0.82 to 3.05), although we found that CD109 positivity was related to chemoresistance. The poor-response group showed higher rates of CD109 expression than the good-response group (93.8% vs 66.7%, p = .047). Also, the CD109 mRNA expression level was 2.88 times higher in the poor-response group as compared to the good-response group (p = .001). CONCLUSIONS: Examining the CD109 expression in patients with OEC may be helpful in predicting survival and chemotherapeutic effect.
Cell Line, Tumor
;
Drug Therapy
;
Humans
;
Polymerase Chain Reaction
;
Prognosis
;
Recurrence
;
Risk Factors
;
RNA, Messenger
2.Primary Glomerulonephritis with Unique C4d Deposition and Concurrent Non-infectious Intermediate Uveitis: a Case Report and Literature Review.
Jong Man PARK ; Harin LEE ; Sangheon SONG ; Eun Young SEONG ; Ihm Soo KWAK ; Sung Who PARK ; Young Keum KIM ; Nari SHIN ; Mee Young SOL
Journal of Korean Medical Science 2018;33(18):e136-
C4 glomerulopathy is a recently introduced entity that presents with bright C4d staining and minimal or absent immunoglobulin and C3 staining. We report a case of a 62-year-old man with C4 glomerulonephritis (GN) and uveitis. He presented to the nephrology department with proteinuria and hematuria. The patient also had intermediate uveitis along with proteinuria and hematuria. A kidney biopsy that was performed in light of continuing proteinuria and hematuria showed a focal proliferative, focal sclerotic glomerulopathy pattern on light microscopy, absent staining for immunoglobulin or C3 by immunofluorescence microscopy, with bright staining for C4d on immunohistochemistry, and electron-dense deposits on electron microscopy. Consequently, C4 GN was suggested as the pathologic diagnosis. Although laser microdissection and mass spectrometry for glomerular deposit and pathologic evaluation of the retinal tissue were not performed, this is the first report of C4 GN in Korea and the first case of coexisting C4 GN and uveitis in the English literature.
Biopsy
;
Diagnosis
;
Glomerulonephritis*
;
Hematuria
;
Humans
;
Immunoglobulins
;
Immunohistochemistry
;
Kidney
;
Korea
;
Mass Spectrometry
;
Microdissection
;
Microscopy
;
Microscopy, Electron
;
Microscopy, Fluorescence
;
Middle Aged
;
Nephrology
;
Proteinuria
;
Retinaldehyde
;
Uveitis
;
Uveitis, Intermediate*
3.The Role of TWIST in Ovarian Epithelial Cancers.
Kyungbin KIM ; Eun Young PARK ; Man Soo YOON ; Dong Soo SUH ; Ki Hyung KIM ; Jeong Hee LEE ; Dong Hoon SHIN ; Jee Yeon KIM ; Mee Young SOL ; Kyung Un CHOI
Korean Journal of Pathology 2014;48(4):283-291
BACKGROUND: Epithelial-mesenchymal transition (EMT) is associated with tumor hypoxia. EMT is regulated, in part, by the action of TWIST, which inhibits of E-cadherin expression and may interfere with the p53 tumor-suppressor pathway. METHODS: We examined the expression of TWIST, E-cadherin, hypoxia-inducible factor 1alpha (HIF1alpha), and p53 by immunohistochemistry in 123 cases of ovarian epithelial cancers (OEC) to evaluate the role of TWIST in OEC. We assessed the association between protein expression and clinicopathologic parameters. RESULTS: The expression of TWIST, E-cadherin, HIF1alpha, and p53 proteins was found in 28.5%, 51.2%, 35.0%, and 29.3% of cases, respectively. TWIST expression was associated with higher histologic grade and unfavorable survival. TWIST expression was correlated with HIF1alpha expression and reduced E-cadherin expression. The altered HIF1alpha/TWIST/E-cadherin pathway was associated with lower overall survival (OS), while the co-expression of TWIST and p53 was correlated with lower progression-free survival. In the multivariate analyses, TWIST expression was an independent prognostic factor for OS. CONCLUSIONS: Our data imply that TWIST expression could be a useful predictor of unfavorable prognosis for OEC. TWIST may affect the p53 tumor-suppressor pathway. Moreover, hypoxia-mediated EMT, which involves the HIF1alpha/TWIST/E-cadherin pathway may play an important role in the progression of OEC.
Anoxia
;
Cadherins
;
Disease-Free Survival
;
Epithelial-Mesenchymal Transition
;
Immunohistochemistry
;
Multivariate Analysis
;
Prognosis
;
Tumor Suppressor Protein p53
;
Twist Transcription Factor
4.Pathology of Thrombotic Microangiopathy.
Journal of the Korean Society of Pediatric Nephrology 2013;17(1):6-12
Thrombotic microangiopathy (TMA) is a microvascular thrombotic lesion caused by endothelial injury and subsequent formation of platelet rich thrombus. TMA is first described as a classical pathologic feature of HUS/TTP. Renal biopsy finding of TMA represents kidney involvement of HUS/TTP as well as other diseases such as malignant hypertension, drug toxicity, eclampsia, pre-eclampsia, and several systemic infections. Autoimmune diseases and transplant kidney sometime also have TMA. It is needed to consider a complete autoimmune work-up of patients presenting with TMA including tests for ANA, ANCA, and ADAMTS13 inhibitory antibodies, because there are several reports of association with TMA in patients of SLE, anti-phospholipid syndrome, and ANCA-associated vasculitis.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
;
Antibodies
;
Antibodies, Antineutrophil Cytoplasmic
;
Antiphospholipid Syndrome
;
Autoimmune Diseases
;
Biopsy
;
Blood Platelets
;
Drug Toxicity
;
Eclampsia
;
Female
;
Humans
;
Hypertension, Malignant
;
Kidney
;
Pre-Eclampsia
;
Pregnancy
;
Thrombosis
;
Thrombotic Microangiopathies
;
Transplants
5.Ectomesenchymal Chondromyxoid Tumor in the Anterior Tongue: Case Report of a Unique Tumor.
Min Gyoung PAK ; Kyung Bin KIM ; Nari SHIN ; Woo Kyung KIM ; Dong Hoon SHIN ; Kyung Un CHOI ; Mee Young SOL
Korean Journal of Pathology 2012;46(2):192-196
Ectomesenchymal chondromyxoid tumor (ECMT) is a rare tumor, exclusively arising in the anterior tongue. Thirty-eight cases have been reported in the English literature. It usually presents as a sessile protrusion and shows round to spindle cells embedded in myxoid to chondroid stroma. Tumor cells are almost always positive for polyclonal glial fibrillary acidic protein (GFAP). We report our experience in the recent treatment of a case of ECMT, the third case in 3 years. The mass in the anterior tongue revealed characteristic morphologic features of ECMT and the expression of polyclonal GFAP. Although ECMT should be differentiated from other mesenchymal tumors including myoepithelioma, its clinical, morphological, and immunohistochemical features enable its diagnosis, especially when pathologists are aware of it.
Glial Fibrillary Acidic Protein
;
Myoepithelioma
;
Tongue
6.A Case of Severe Acute Kidney Injury by Near-Drowning.
Eun Young SEONG ; Harin RHEE ; Naria LEE ; Sung Jun LEE ; Sang Heon SONG ; Dong Won LEE ; Soo Bong LEE ; Mee Young SOL ; Ihm Soo KWAK
Journal of Korean Medical Science 2012;27(2):218-220
Acute kidney injury (AKI) secondary to near-drowning is rarely described and poorly understood. Only few cases of severe isolated AKI resulting from near-drowning exist in the literature. We report a case of near-drowning who developed to isolated AKI due to acute tubular necrosis (ATN) requiring dialysis. A 21-yr-old man who recovered from near-drowning in freshwater 3 days earlier was admitted to our hospital with anuria and elevated level of serum creatinine. He needed five sessions of hemodialysis and then renal function recovered spontaneously. Renal biopsy confirmed ATN. We review the existing literature on near-drowning-induced AKI and discuss the possible pathogenesis.
Acute Kidney Injury/*diagnosis/*etiology
;
Anuria/etiology
;
Creatinine/blood
;
Humans
;
Kidney Tubular Necrosis, Acute/etiology/pathology
;
Male
;
Near Drowning/*complications
;
Renal Dialysis
;
Young Adult
7.Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers.
Kyungbin KIM ; Won Young PARK ; Jee Yeon KIM ; Mee Young SOL ; Dong Hun SHIN ; Do Youn PARK ; Chang Hun LEE ; Jeong Hee LEE ; Kyung Un CHOI
Korean Journal of Pathology 2012;46(6):532-540
BACKGROUND: Tumor hypoxia is associated with malignant progression and treatment resistance. Hypoxia-related factors, such as carbonic anhydrase IX (CA IX), glucose transporter-1 (GLUT-1), and vascular endothelial growth factor (VEGF) permit tumor cell adaptation to hypoxia. We attempted to elucidate the correlation of these markers with variable clinicopathological factors and overall prognosis. METHODS: Immunohistochemistry for CA IX, GLUT-1, and VEGF was performed on formalin-fixed, paraffin-embedded tissues from 125 cases of ovarian epithelial cancer (OEC). RESULTS: CA IX expression was significantly associated with an endometrioid and mucinous histology, nuclear grade, tumor necrosis, and mitosis. GLUT-1 expression was associated with tumor necrosis and mitosis. VEGF expression was correlated only with disease recurrence. Expression of each marker was not significant in terms of overall survival in OECs; however, there was a significant correlation between poor overall survival rate and high coexpression of these markers. CONCLUSIONS: The present study suggests that it is questionable whether CA IX, GLUT-1, or VEGF can be used alone as independent prognostic factors in OECs. Using at least two markers helps to predict patient outcomes in total OECs. Moreover, the inhibition of two target gene combinations might prove to be a novel anticancer therapy.
Anoxia
;
Carbonic Anhydrases
;
Glucose
;
Humans
;
Immunohistochemistry
;
Mitosis
;
Mucins
;
Necrosis
;
Neoplasms, Glandular and Epithelial
;
Ovarian Neoplasms
;
Recurrence
;
Survival Rate
;
Vascular Endothelial Growth Factor A
8.Molecular Biological Characteristics of Differentiated Early Gastric Cancer on the Basis of Mucin Expression.
Nari SHIN ; Hye Yeon KIM ; Woo Kyung KIM ; Min Gyung PARK ; Kyung Bin KIM ; Dong Hoon SHIN ; Kyung Un CHOI ; Jee Yeon KIM ; Chang Hun LEE ; Gi Young HUH ; Mee Young SOL ; Do Youn PARK
Korean Journal of Pathology 2011;45(1):69-78
BACKGROUND: It is clear that the biologic characteristics of gastric cancer are different on the basis of mucin phenotypes. However, there are unabated controversies on the exact biologic differences of mucin expression in gastric cancer. METHODS: We analyzed various protein expressions and microsatellite instability (MSI) status based on mucin expression in 130 differentiated early gastric adenocarcinoma cases. Furthermore, we evaluated the genomic alternation in 10 selected differentiated early gastric adenocarcinoma cases using array based comparative genomic hybridization (aCGH). RESULTS: Intestinal mucin predominant subtype showed significantly elevated p53 protein and caudal-related homeobox 2 expression, and delocalization of beta catenin expressions compared to the gastric mucin predominant subtype. On MSI status, the gastric mucin predominant subtype more frequently showed unstable status than the intestinal mucin predominant subtype. CGH study showed more frequent chromosomal gain and loss in the intestinal mucin predominant subtype than the gastric mucin predominant subtype, albeit without statistical significance. Interestingly, there were significant differences in chromosomal alternation between four mucin phenotypes. CONCLUSIONS: Study results suggest possible different points of biologic behaviors in early differentiated gastric adenocarcinomas by mucin expression type.
Adenocarcinoma
;
beta Catenin
;
Comparative Genomic Hybridization
;
Gastric Mucins
;
Genes, Homeobox
;
Microsatellite Instability
;
Mucins
;
Phenotype
;
Population Characteristics
;
Stomach Neoplasms
;
Succinimides
;
Tumor Suppressor Protein p53
9.Clinicopathologic Factors for Prediction of Lymph Node Metastasis in Submucosally Invasive Colorectal Carcinoma.
Seung Hyun LEE ; Hyun Jeong KANG ; Byung Kwon AHN ; Sung Uhn BAEK ; Hee Kyung CHANG ; Nham Gun OH ; Mee Young SOL ; Do Youn PARK
Journal of the Korean Surgical Society 2011;80(2):111-118
PURPOSE: The purpose of this study is to identify useful clinicopathologic factors for the prediction of lymph node metastasis in submucosally invasive colorectal carcinoma. METHODS: A total of fifty-four cases of colorectal carcinomas with submucosal invasion were included. The patients underwent curative resection with en bloc lymph node dissection. Clinical features such as age, gender, tumor size and tumor location were reviewed. Histopathologic examinations for tumor growth type, differentiation, depth of tumor invasion, lymphovascular invasion, neural invasion, tumor budding and peritumoral inflammation were performed. The expression of E-cadherin, beta-catenin, Smad4, p53 and Ki-67 were examined by immunohistochemistry. The correlation between the clinicopathologic factors and lymph node metastasis was evaluated. RESULTS: From the 54 patients with submucosally invasivecolorectal carcinoma, lymph node metastasis was identified in 13 cases (24.1%). The incidence of lymph node metastasis was significantly higher in cases positive for lymphovascular invasion (55.6% vs. 17.8%, P=0.028) and positive for tumor budding (47.4% vs. 11.45%, P=0.006). Cases negative for Smad4 had a higher tendency for incidence of lymph node metastasis (28.6% vs. 15.8%, P=0.341). Other clinicopathologic and immunohistochemical features were irrelevant to the lymph node status. In multivariate analysis, only tumor budding was an independent predictor of lymph node metastasis (P=0.051). CONCLUSION: Lymphovascular invasion and tumor budding were predictive factors of lymph node metastasis in submucosally invasive colorectal carcinoma. The incidence of lymph node metastasis of submucosally invasive colorectal carcinoma was not low. Careful selection for avoiding surgery in submuocally invasive colorectal carcinoma should be considered.
beta Catenin
;
Cadherins
;
Colorectal Neoplasms
;
Humans
;
Immunohistochemistry
;
Incidence
;
Inflammation
;
Lymph Node Excision
;
Lymph Nodes
;
Multivariate Analysis
;
Neoplasm Metastasis
10.Clinical Relevance of Elevated Levels of Serum Soluble Interleukin-2 Receptor alpha (sIL-2Ralpha) in Patients with Non-Hodgkin's Lymphoma.
Seon A JO ; Sang Hyun HWANG ; Chulhun L CHANG ; Shine Young KIM ; Ho Jin SHIN ; Joo Seop CHUNG ; Mee Young SOL ; Eun Yup LEE
The Korean Journal of Laboratory Medicine 2010;30(6):600-605
Levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) are known to increase in the sera of patients with certain malignancies, including malignant lymphoma. This study aimed to assess the clinical significance of the sIL-2Ralpha level in non-Hodgkin's lymphoma (NHL). We used ELISA to measure the sIL-2Ralpha levels in 48 newly diagnosed and untreated patients with NHL and evaluated the correlation between the sIL-2Ralpha levels and clinical characteristics and the International Prognostic Index (IPI). We monitored serum sIL-2Ralpha in 7 patients to compare the changes in their clinical progress with these levels. High levels of serum sIL-2Ralpha (> or =2,000 U/mL) correlated well with parameters defining the high risk group according to the IPI, i.e., high tumor burden at diagnosis (stage III+IV) and lactate dehydrogenase > or =472 U/L. The levels were also associated with B symptoms, bone marrow involvement, and poor response to therapy. The sIL-2Ralpha level decreased during complete remission and was elevated during disease progression or relapse. A high level of sIL-2Ralpha was significantly associated with a low survival rate. These results suggest that serum sIL-2Ralpha might be useful as a biomarker for evaluating the prognosis of patients with NHL at the time of diagnosis and during therapy. A well-controlled, large-scale study is needed to clarify the clinical significance of sIL-2Ralpha in specific groups of NHL.
Aged
;
Biological Markers/blood
;
Female
;
Humans
;
Interleukin-2 Receptor alpha Subunit/*blood
;
L-Lactate Dehydrogenase/blood
;
Lymphoma, Non-Hodgkin/*diagnosis/metabolism/mortality
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Survival Rate

Result Analysis
Print
Save
E-mail